Efficacy of buffered acetylsalicylic acid and enteric-coated acetylsalicylic acid on platelet aggregation in patients with chronic coronary syndrome and type 2 diabetes (CASCADE): single-center observational comparative study
Background. There is a lack of data on the incidence of aspirin nonresponsiveness and the efficacy of different forms of ASA in patients with diabetes.Aim. To evaluate the efficacy of buffered versus enteric-coated ASA based on the frequency of high residual platelet reactivity (HRPR) as measured by...
Saved in:
Main Authors: | Zh. D. Kobalava, A. S. Pisaryuk, A. A. Filkova, E. S. Tukhsanboev, A. N. Amirova, A. D. Korneichuk, G. S. Pavlikov, L. R. Burkhanova, I. A. Meray, M. A. Panteleev, A. N. Sveshnikova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2025-03-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/6282 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of buffered and enteric-coated acetylsalicylic acid on platelet aggregation in patients with stable coronary artery disease and type 2 diabetes (CASCADE): rationale and design of a single-center observational comparative study
by: Zh. D. Kobalava, et al.
Published: (2025-02-01) -
Study of pharmaceutical properties of low-dosage enteric-coated acetylsalicylic acid
by: V. V. Rafalsky, et al.
Published: (2016-02-01) -
ON THE 125TH ANNIVERSARY OF ACETYLSALICYLIC ACID
by: I. N. Bokarev, et al.
Published: (2016-01-01) -
Antithrombotic effect of different acetylsalicylic acid drug formulations: is there a difference?
by: A. V. Sidorov
Published: (2021-11-01) -
COMBINED ACETYLSALICYLIC ACID TABLETS TECHNOLOGY
by: A. V. Simonyan, et al.
Published: (2019-01-01)